Staphylococci. Methicillin-resistant S. aureus (MRSA) isolates appeared shortly after the introduction of methicillin, the first penicillinase-resistant ␤-lactam to come into clinical use, which was in 1960 (5) . Methicillin resistance is due to the acquisition of SCCmec (staphylococcal cassette chromosome mec [51] , formerly termed the mec determinant). SCCmec is considered a novel type of mobile element that has been termed a "resistance island," in analogy to pathogenicity islands (54, 58) . SCCmec is thought to be of nonstaphylococcal origin, as it differs from the rest of the staphylococcal chromosome in its GϩC content. However, its reservoir has not been clearly identified. Several SCCmec subtypes have been characterized (4, 51, 63 ) that differ in their sizes, genes, and the additional resistance determinants that they contain, as well as in their clonal distributions. The gene responsible for methicillin resistance, mecA, encodes an additional PBP, PBP2Ј (synonym PBP2a), that has a lower affinity to methicillin and other ␤-lactam derivatives.
One of the characteristic features of methicillin resistance is its heterogeneity; in a given population of S. aureus, the majority of cells are often resistant to a relatively low concentration of methicillin, while a small proportion (10 Ϫ8 to 10 Ϫ2 of the cells) are able to grow at higher concentrations. This heterogeneity is the reason for the failure of ␤-lactam therapy in MRSA infections. It has been demonstrated that the level of resistance does not necessarily correlate with the amount of PBP2Ј expressed (86) , but there is no satisfactory genetic or biochemical explanation for this phenomenon, although many mutations leading from high-level resistance to heteroresistance in vitro have been identified (for a review, see reference 11).
In the absence of the mecA gene, staphylococci may acquire ␤-lactam resistance via mutations that lead to overexpression of endogenous PBP2 and/or PBP4 or mutations that reduce their penicillin affinities (43, 50) . Clinical S. aureus isolates with such mutations have been identified and have been termed MODSA in reference to their modified PBPs (106) . Furthermore, a decreased affinity of PBP3 for ␤-lactams was found to lead to low-level methicillin resistance in Staphylococcus epidermidis (78) . Overexpression of a penicillinase in a specific genetic background, in the so-called borderline resistant S. aureus (BORSA), may also lead to low-level methicillin resistance (6) . These two types of resistance mechanisms have less clinical impact than true methicillin resistance in S. aureus and were never observed to achieve more than borderline resistance in clinical isolates. Pneumococci. In Streptococcus pneumoniae, target alteration is the main mechanism of resistance to penicillin. In contrast to methicillin resistance in staphylococci, penicillin resistance arises by modification of endogenous PBPs. The first PBPs to be affected are PBP2b or the essential PBP, PBP2x, depending on the antibiotic used for selection (41, 59) . Mutations in just three amino acids in the active-site region of PBP2x are sufficient to create low-affinity derivatives (55) . Additional gene diversity is created by horizontal exchange of DNA fragments between strains or even with commensal streptococci, resulting in highly mosaic genes. Some very low affinity PBP2x variants from clinical isolates contain more than 100 amino acid substitutions spread over the entire sequence (47, 61, 83) . Mutations in PBP2x and PBP2b are sufficient for midlevel resistance, but to achieve high-level penicillin resistance, all six endogenous PBPs can be modified. The combination of several highly resistant PBPs may raise the penicillin MIC 100-to 1,000-fold (45, 114) . Similar to staphylococci, it was found that additional genes other than pbp genes are involved in pneumococcal ␤-lactam resistance, as transformation of susceptible strains with only the pbp genes from highly resistant strains was not sufficient to achieve the same level of resistance (46, 96) .
Enterococci. Enterococci are naturally less susceptible to ␤-lactams than pneumococci or staphylococci (35) . Their intrinsic ␤-lactam resistance is due to endogenous low-affinity PBP5, which is not essential (91) . Acquired resistance to higher antibiotic concentrations is associated with the overproduction of PBP5 and/or a decreased affinity of PBP5 for the ␤-lactam (34) . However, the role of PBP5 in high-level resistance is likely to depend on additional factors. The expression of pbp5 alleles from highly resistant strains in a penicillin-susceptible pbp5 deletion mutant of Enterococcus faecium conferred only moderate, not high-level, resistance (91) . As the sensitive PBPs are inactivated by ␤-lactams, PBP5 is able to synthesize muropeptide dimers and trimers in abundance, but higher oligomers are reduced (92) . Inactivation of PBP5 of Enterococcus faecalis leads to hypersusceptibility to all ␤-lactams (93) . Interestingly, the first low-affinity PBP found to be located on a plasmid is PBP3r from Enterococcus hirae, which is almost identical to PBP5 (80, 82) .
STRUCTURAL CHARACTERISTICS OF NORMAL AND LOW-AFFINITY PBPS
Depending on the species, bacteria contain between four and eight PBPs, which are divided into several classes (39) . Monofunctional PBPs contain a penicillin-binding (PB) domain and largely perform accessory functions in peptidoglycan synthesis. Class A multimodular, bifunctional PBPs contain a non-PB (n-PB) module that has transglycosylase activity, which has been demonstrated for PBP1a and PBP1b in Escherichia coli (71) and PBP2 in S. aureus (79) . The PB domains of class A PBPs perform the transpeptidase function. Class A PBPs can therefore perform all necessary functions in peptidoglycan cross-linking.
Class B multimodular PBPs contain an n-PB domain which does not appear to have transglycosylase activity and a PB domain which has transpeptidase activity. The exact function of the n-PB module is unknown, but it may mediate interaction with other proteins of the cell wall synthesis machinery (53) and it is essential for folding (39) . The low-affinity PBPs of enterococci and staphylococci are closely related and form PBP subclass B1, which stands apart from the unmodified class B PBPs and also from S. pneumoniae PBP2x (39) . As an exception, Bacillus subtilis PBP3 groups in the B1 cluster but has not been linked to any low-affinity property (70) . Class B PBPs must cooperate with either a monofunctional transglycosylase or the transglycosylase domain of a class A PBP to synthesize cross-linked peptidoglycan. In S. aureus, this assumption was recently supported by the observation that PBP2Ј needs the intact transglycosylase module of the resident PBP2 in order to confer methicillin resistance (79) . However, there are indications that PBP2Ј is a very poor transpeptidase that only barely VOL. 47, 2003 MINIREVIEW 839 allows the cells to survive the action of methicillin. When highly methicillin resistant S. aureus strain COL is grown in the presence of methicillin concentrations sufficient to inactivate the endogenous PBPs, PBP2Ј forms a poorly cross-linked cell wall containing mainly un-cross-linked muropeptides and only a few muropeptide dimers or trimers. The same strain grown in antibiotic-free medium produces highly cross-linked peptidoglycan (25) .
Little is known about the structural changes that give rise to low-affinity PBPs. The recent determination of the structure of E. faecium PBP5fm, which belongs to the B1 group of PBPs, has provided some evidence into the mechanism that makes these proteins resistant to ␤-lactams. The active site of PBP5fm is surrounded by a number of amino acids that are strongly conserved in class B1 PBPs but not in PBPs of other classes and that may confer greater rigidity and a reduced affinity of ␤-lactams for the active site of this group of proteins (87) .
In PBP2x from highly resistant strain SP328 (27) , the helix that harbors the SXN motif is highly flexible, causing the serine to point away from the active site and leading to a decreased affinity for the antibiotic. Important amino acid exchanges are T338A in the STMK motif, which leads to a reduced rate of acylation by the ␤-lactam (27, 69) . In a variant of PBP2x that has a higher affinity for penicillin (40) , the active site lies in a deep groove of the protein. In contrast, the flexible architecture of PBP2x from resistant strain SP328 results in an "open" active-site pocket that may be able to accommodate branched peptidoglycan precursors (27) , for which it apparently exhibits a substrate preference, as will be discussed below. Although kinetic studies of low-affinity PBP2x also demonstrated that it has a reduced affinity for a structural analog of the linear stem peptide (69, 117) , studies with an analog of the branched stem peptide have not been done to confirm the substrate preference hypothesis.
LOW-AFFNITY PBPS AND VANCOMYCIN RESISTANCE
The recent first report of a vancomycin-resistant S. aureus isolate that has acquired the vanA gene from enterococci (19) raises a number of questions: does the incorporation of Dlactate into the peptidoglycan precursor affect the function of the cross-linking enzymes, particularly PBP2Ј? If yes, how does this affect resistance to agents other than vancomycin?
Some indications of the answers to this problem may be found in studies conducted with enterococci. It appears that the presence of D-lactate does not affect peptidoglycan crosslinking under unchallenged growth conditions (15, 21) . However, vancomycin and ␤-lactams have been shown to exhibit a synergistic action in vancomycin-resistant enterococci, which indicates that their low-affinity PBPs do not cope well with the modified stem peptides (2, 42) .
In a recent study with S. aureus (23) , the addition of D-serine, D-threonine, and D-phenylalanine to the growth medium reduced the levels of cross-linking and methicillin resistance, as these amino acids were efficiently incorporated in the fifth position of the peptidoglycan stem peptide. The same effect has been observed when glycine was added to the growth medium (22) . However, these experiments did not include Dlactate, and the effect on vancomycin resistance was not determined. Although the most recent of these studies concluded that vanA-mediated vancomycin resistance and mecA-mediated methicillin resistance may be mutually exclusive, this hypothesis does not hold true for the recently reported vancomycin-resistant S. aureus strain that also carries mecA and for which the oxacillin MIC is 16 g/ml (19) .
BIOSYNTHESIS OF BRANCHED CELL WALL PEPTIDES AND IMPACT ON ␤-LACTAM RESISTANCE
Cross-linking of peptidoglycan ( Fig. 1) by transpeptidases (PBPs) always occurs via a diamino acid in the stem peptide, generally meso-diaminopimelic acid, L-Lys, or L-Orn. Crosslinks occur either directly or via an interceding spacer (or interpeptide), which consists of one to five amino acids and which branches off the diamino acid. The interpeptide may contain amino acids in the L or D conformation (88) .
In S. aureus, the pentaglycine interpeptide is synthesized in a sequential fashion on the cytoplasmic face of the membrane, with lipid II as a substrate (57, 66) , where the first glycine is attached to the ε-amino group of L-lysine (56, 97) . The glycine donor is glycyl-tRNA (65), and a fraction of tRNAs is exclusively used in interpeptide synthesis (18) . Although tRNAs participate in interpeptide formation, the reaction is not inhibited by antibiotics that target protein translation, and thus, it was concluded that interpeptide synthesis is achieved by a nonribosomal mechanism (57) . In an alternative pathway, in species such as E. faecium, whose interpeptide contains Damino acids, the amino acids are incorporated from phosphate precursors (17, 88) .
FemABX protein family. The branched peptide chain is synthesized by a family of nonribosomal peptidyl transferases (Fig. 2) that use either the lipid II-linked peptidoglycan precursor or, alternatively, the soluble, UDP-MurNAc-linked stem peptide (cf. Fig. 1 ) as a substrate for the addition of one or several additional amino acids to the peptidoglycan stem peptide in a sequential fashion. The impact of these factors on cell wall composition and, in clinically relevant species, on antibiotic resistance is outlined below.
Staphylococcus. The cause of heterogeneity in methicillin resistance was initially investigated by transposon-mediated mutagenesis (9) , which led to the identification of a number of loci whose inactivation lowered the resistance level, and the terms fem factors (for factors essential for methicillin resistance) and aux factors (for auxiliary) were coined (8, 12, 26) . It was shown that all fem factors are housekeeping genes, most of which play a role in cell wall biosynthesis. Mutation of the femAB operon affects the glycine content in the cell wall (64) . It was determined that FemA specifically adds glycines 2 and 3 of the pentaglycine interpeptide, while FemB, which shares 39% identity and 59% similarity with FemA on the amino acid level, adds glycines 4 and 5 (28) . femAB mutants completely lose resistance to methicillin and become hypersusceptible to many unrelated antibiotics (62) . femAB mutant cells are pseudomulticellular with thickened cell walls and abnormal septa due to impaired cell wall turnover and are resistant to the glycyl-glycine endopeptidase lysostaphin (49) . It is clear from these observations that not only low-affinity PBP2Ј but also the endogenous PBPs cope very badly with the shortened pentaglycine interpeptide. FemA and FemB homologs have been identified in all staphylococcal species tested (1, 112).
The factor (femX) that catalyzes the incorporation of the first glycine long remained elusive. Inactivation of femA or femB yielded viable cells, but it was demonstrated that they had acquired compensatory mutations in order to survive (62) . It was deduced that the inactivation of femAB would otherwise be lethal and that the postulated femX was probably essential (60) . The advent of whole-genome sequencing made it possible to search the complete S. aureus genome for additional homologs of femAB; and three sequences were identified and named fmhA, fmhB, and fmhC (for fem homolog) (109) . fmhA and fmhC (alternative name, eprH [99] ) were inactivated without a discernible phenotype, while inactivation was impossible for fmhB, making it a likely femX candidate (109) . A promoter insertion strategy in which cells could be depleted of FmhB was used to demonstrate its role in the addition of glycine 1 of the interpeptide chain. FmhB depletion leads to the virtual disappearance of glycine-substituted muropeptide monomers and to a significant reduction in the degree of peptidoglycan crosslinking. The introduction of this construct into an MRSA background causes a complete loss of resistance to methicillin (84) . It can be concluded from these observations that the staphylococcal cell can tolerate, if barely, the reduction of the interpeptide to one glycine, but the complete lack of glycine substitution is lethal. In addition, PBP2Ј, the low-affinity PBP responsible for methicillin resistance, is unable to perform its function in the absence of a five-membered interpeptide chain.
Pneumococcus. In S. pneumoniae, the peptide side chain, consisting of Ala 2 or Ser-Ala, is dispensable (90) . In an early study of the pneumococcal cell wall, Garcia-Bustos and Tomasz (36) analyzed a number of penicillin-susceptible and -resistant clinical strains and observed branched as well as unbranched peptidoglycan stem peptides. While in resistant strains there was a large amount of Ala 2 -or Ser-Ala-substituted peptides, in susceptible strains, the situation was variable: in the clinical strains analyzed, the muropeptides were predominantly unsubstituted, whereas in laboratory strain R6 there was a significant fraction of branched muropeptides present. In both the susceptible and the resistant strains ana- has become quite large, and they are shown in an enlarged inset. The GenBank database was searched with the BLAST program (http://www.ncbi.nlm.nih.gov/BLAST/) (3) by using S. aureus FmhB as the query sequence. In the case of Streptococcus equi and Streptococcus pyogenes, three FemABX homologs were found, two of which are related to FibA/MurM of S. pneumoniae and one of which is related to FibB/MurN of S. pneumoniae. Unfinished microbial genomes were searched by using the tblastn program (http://www.ncbi.nlm.nih.gov/Microb_blast/unfinishedgenome.html). Preliminary sequence data from unfinished genomes were obtained from The Institute for Genomic Research website at http://www.tigr.org and from the Sanger Center at http: //www.sanger.ac.uk. In the case of MurM, where multiple, more than 90% identical alleles are available, one representative sequence (that of strain R36A) was chosen. Protein sequences were aligned by using the ClustalW program (102) , and the dendrogram was constructed by using the TreeView program (75) .
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on July 20, 2012 by guest http://aac.asm.org/ lyzed, the muropeptide monomer fractions contained a detectable amount of nonsubstituted muropeptides; but the dimer, trimer, and oligomer fractions appeared to contain almost exclusively substituted muropeptides. These findings led to the conclusion that the PBPs exhibit a substrate preference for substituted stem peptides; the preference appeared more marked in resistant strains, which have modified, low-affinity PBPs. In a penicillin-resistant transformant of strain R6, nonbranched muropeptide dimers were undetectable, leading Garcia-Bustos and Tomasz (36) to suggest that PBP2x may discriminate against unsubstituted stem peptides, a notion that has recently been supported by its crystal structure (discussed above).
The genes for the alanine and/or serine transferases of S. pneumoniae have recently been identified by two independent groups (33, 114) and named murMN and fibAB, respectively. Inactivation of these genes in penicillin-resistant strains results in greatly decreased levels of resistance to ␤-lactams (reductions of more than 32-fold), with a complete breakdown of resistance to cefoxitin, which predominantly targets PBP2x. The MIC is reduced twofold for penicillin-sensitive laboratory strain R6. In addition, the level of total cell wall cross-linking is reduced (114) . As might be expected with such a weakened cell wall and in analogy to femAB mutants (62), murMN mutants are hypersusceptible to all other classes of cell wall synthesis inhibitors (32) . Surprisingly, laboratory strain R36A contains a very small amount of alanine-or serine-substituted muropeptides compared to the amounts in strain R6, even with an intact murMN operon (33) . The murM and murN genes of laboratory strains R6 and R36A, which have essentially the same genetic backgrounds, differ in only two and one amino acid positions, respectively. It is conceivable that variations in the transcriptional activity of murMN may cause this significant difference in their peptidoglycan compositions.
As is the case with many genes in pneumococci (44, 45) , the murMN genes, like PBP2x, exhibit a mosaic structure which may explain the strain-dependent differences in branched muropeptide content. The variability of the murMN genes appears to be responsible for variations in the catalytic efficiencies of their products (30, 95) . Again, in resistant strains, a larger amount of branched muropeptides indicates that these strains contain murM alleles that encode a highly efficient enzyme. The presence of a high-efficiency murM allele appears to be a prerequisite for the acquisition of high-level resistance to penicillin by remodeled, low-affinity PBPs, as only transformation by both the low-affinity PBPs and the murMN genes from a resistant donor strain results in high-level resistance in a susceptible recipient (95) .
The correlation between branched peptidoglycan and lowaffinity PBPs as the sole resistance mechanisms may be questionable due to a report that dissociated penicillin resistance from branched peptidoglycan peptides by transformation (89) . When a susceptible, directly cross-linked strain was transformed with DNA from a resistant donor with low-affinity PBPs and a branched-chain peptidoglycan, the first round of transformation resulted in resistant strains that had acquired both the branched peptides and the low-affinity PBPs of the donor. However, in a second round of transformation, resistance was no longer coupled to the branched-chain peptidoglycan, as the strains were resistant to penicillin but had retained the recipient's peptidoglycan structure. Examination of the PBP profiles indicated that most of these second-round transformants had acquired changes, possibly point mutations, leading to PBPs with reduced ␤-lactam affinities. Conceivably, mutations in genes other than murMN or pbp were selected in these experiments; therefore, the study does not necessarily invalidate the link between resistance and peptidoglycan structure.
The description of MurMN in S. pneumoniae has given valuable insights into the specificity of the FemABX family of peptidyl transferases. Filipe et al. (31) have analyzed a set of murM alleles and pinpointed the region that determines which amino acid is incorporated into the peptidoglycan precursor. The exchange of codons 244 to 274 between murM alleles from two strains incorporating mainly seryl-alanine (strain KY17) or dialanine (strain DE1) determined the ratio of serine versus alanine that was incorporated. In particular, the amino acid in position 260 was determined as the major difference in these two strains. A single amino acid exchange (T260K) in murM of strain KY17, indeed, slightly increased the alanine content of the peptide side chain, but other residues in the region from codons 244 to 274 must be assumed to affect the specificity of murM as well. A Q27E/T mutation had no measurable effect, although it was suggested that this amino acid position may be involved in catalysis in FemX of Weissella viridescens (see below) (48) . In addition, the deletion of as few as 50 amino acids at the N terminus or 10 amino acids at the C terminus inactivated MurM. This effect was also observed in the case of FemA and FemB of S. aureus, in which point mutations at the C terminus, which lead to a stop codon, completely inactivated the proteins (60) .
Lactobacillus. Hegde and Shrader (48) have recently identified FemX in W. viridescens (formerly Lactobacillus viridescens) and were able to reconstitute the addition of glycine to the soluble, UDP-linked peptidoglycan precursor from glycyltRNA in vitro. Their attempt to reconstitute the same reaction with S. aureus FmhB was unsuccessful, probably because this reaction occurs on lipid II, whereas in W. viridescens it occurs on the soluble precursor (cf. Fig. 1) .
Enterococcus. The catalytic activities of the FemABX homologs in E. faecalis have been analyzed (16) . Two homologous open reading frames were found. Both orf1 (coding for a protein of 48.3 kDa) and orf2 (coding for a protein of 46 kDa) were recombinantly expressed and reconstituted in an in vitro assay. Only the product of orf2 has UDP-MurNAc-pentapeptide:L-alanine ligase activity and therefore corresponds to S. pneumoniae MurM, to which it is closely related (Fig. 2) . It is conceivable that a coupled reaction with Orf1 and Orf2 would demonstrate the activity of Orf1, which groups with MurN in Fig. 2 . The effect of mutations of orf1 and orf2 on ␤-lactam resistance has not yet been determined.
Endopeptidase resistance factors. The family of FemABXlike proteins also includes immunity factors that protect producers of interpeptide-specific endopeptidases against their own products by substituting some of the amino acid positions in their interpeptides. epr (endopeptidase resistance) from Staphylococcus capitis (100) and lif (lysostaphin immunity factor) from Staphylococcus simulans bv. staphylolyticus (20, 103) incorporate serine into the interpeptide at specific positions and thereby make the cell wall resistant to glycyl-glycine endopeptidases such as lysostaphin (29, 108 (Fig. 2) . As mutation of these genes did not appear to cause a phenotype (99, 109) , fmhA and fmhC may be silent or almost inactive remnants of genes encoding serine-incorporating enzymes in S. aureus. They may even be responsible for the somewhat elevated level of serine incorporation that was observed in a partial femAB mutant (24) . In Streptococcus milleri, the endopeptidase millericin B (milB) is coorganized with the immunity factor milF. MilF substitutes leucine in the interpeptide for the endogenous threonine (13) . In Streptococcus zooepidemicus, zoocin (zooA) and its corresponding immunity factor, zif, have been described (94) . However, it is unclear whether Zif substitutes any amino acids in the interpeptide (7).
ROLE OF BRANCHED-CHAIN PEPTIDES IN CELL DIVISION
In addition to their impact on ␤-lactam resistance, branched cell wall peptides play an important role in cell division. femAB mutants, which have a shortened interpeptide, exhibit thickened septa and are pseudomulticellular due to impaired cell separation (49) . It has been shown that endogenous glycylglycine endopeptidases are involved in cell separation, and femAB mutants are largely resistant to the actions of such endopeptidases (98) , which explains this defect in cell division. On the other hand, the major autolysin Atl, which is implicated in lytic death in the presence of penicillin (described above), is not impaired by the shortened interpeptide, as its mature domains have endo-␤-N-acetylglucosaminidase and N-acetylmuramyl-L-alanine amidase activities (101), and is not affected by the interpeptide structure.
ANCHORING OF CELL SURFACE PROTEINS
In addition to their influence on resistance to ␤-lactams and their crucial role in cell wall integrity and cell division, branched-chain muropeptides also play a role in virulence. In S. aureus, important virulence factors are covalently attached to the cell wall interpeptide. Examples are protein A, fibrinogen-binding protein (clumping factor), and other so-called MSCRAMMs (microbial surface components recognizing adhesive matrix molecules) that enable adhesion to host tissues (73, 76) . Branched side chains that do not participate in peptidoglycan cross-linking serve as anchoring points for such cell wall-linked proteins. Cell wall-localized proteins carry a characteristic C-terminal sorting signal with a conserved LPXTG sequence (72) that is recognized in S. aureus by the enzyme sortase (SrtA) (67) . This enzyme tethers the proteins to the interpeptide in a transpeptidase reaction, which occurs on lipid II on the extracellular face of the membrane (77, 85) . It has been shown that SrtA will not accept linear stem peptides lacking glycine as a substrate (85) and that with the shortened interpeptides containing only one and three glycines in femAB and femB mutants, respectively, sorting of cell wall proteins is impaired (107) . In sortase mutants (67, 68) , virulence is reduced due to an impairment of the anchoring of cell surface proteins. In analogy, in femAB mutant strains, the truncated muropeptide side chains are expected to cause a reduction in virulence due to the concurrent inhibition of the sorting reaction.
A second sortase, SrtB, was found to specifically link IsdC (encoded by the iron-responsive surface determinant locus of S. aureus) to the cell wall via an NPQTN sequence (68) .
It may be assumed that in other species as well a sortase catalyzes attachment of proteins to the cell wall via the branched peptides. In S. pneumoniae, neuraminidase contains a sorting signal, and several cell wall-localized proteins in enterococci also contain this signature sequence (73) . A sortase has indeed been described recently in Listeria monocytogenes, whose cell wall peptides are directly cross-linked via mesodiaminopimelic acid (14) , indicating that the substrate requirements for each sortase correspond to the species' peptidoglycan structure.
CONCLUSION
The FemABX protein family has emerged as a broadly distributed group of peptidoglycan stem peptide peptidyl transferases. The interpeptide serves as a means for cross-linking of the cell wall, mediated by the PBPs. Some PBPs appear to exhibit a marked substrate preference for the peptide side chain, as may be the case with PBP2x in S. pneumoniae. In S. aureus, the PBPs are unable to function at all if the interpeptide is lost. The reduction in length or the absence of the interpeptide impairs the structure of the cell wall and renders ␤-lactam-resistant strains that rely on low-affinity PBPs susceptible to the antibiotics. A subgroup of FemABX family members serve as immunity factors in producers of interpeptidespecific endopeptidases. In addition, the interpeptide plays an important role in cell separation and virulence.
A database search for FmhB homologs yields related sequences in a wide range of bacterial genomes. Species as diverse as Borrelia burgdorferi, Streptomyces coelicolor, and Clostridium perfringens contain a FemABX homolog (Table 1 ; Fig.  2 ). It is not surprising that all species containing a FemABX homolog also bear a peptide side chain in their peptidoglycan (Table 1) , which makes it likely that all homologs encode functional FemABX family proteins. However, the function of these FemABX homologs needs to be confirmed experimentally. Interestingly, in bacteria such as Lactococcus lactis or E. faecium, which contain D-amino acids in their interpeptides, no FemABX homolog can be found. These amino acids are presumed to be attached by an entirely different but not yet identified mechanism (17, 88) .
It appears that the reduction of ␤-lactam affinity has incurred structural restraints on the remodeled PBPs of S. aureus and S. pneumoniae. Their modified active site may exhibit a substrate preference for peptidoglycan precursors with a branched peptide chain. Unfortunately, as only the structures of S. pneumoniae PBP2x and E. faecium PBP5fm have been solved, this remains speculation. The precise requirements for branched peptide peptidoglycan precursors for the resistance VOL. 47, 2003 MINIREVIEW 843
on July 20, 2012 by guest http://aac.asm.org/ level achieved in pneumococci, mediated by low-affinity PBPs with various levels of modification, will need to be carefully analyzed in an isogenic system. In addition, the importance of the branched peptide structure for ␤-lactam resistance in E. faecalis remains to be demonstrated. The observation that S. aureus PBP2Ј and E. faecium PBP5 are poor transpeptidases if the sensitive PBPs are masked by ␤-lactams (25, 92) indicates that these "rescue transpeptidases" (87) have reduced their affinities to ␤-lactams at the cost of efficiency. If the activities of these PBPs are further impaired by a suboptimal substrate, they are simply unable to perform their functions under antibiotic pressure, as is shown by the fem-type mutations in S. aureus and S. pneumoniae and the synergism between vancomycin and ␤-lactams in vancomycin-resistant enterococci.
The global spread of antimicrobial resistance has created a need for new agents for the treatment of bacterial infections. The knowledge that has been gained about the FemABX family of proteins suggests that they are a suitable target for the development of new antimicrobials. If an inhibitor of FemABX proteins was developed, it would be a potent and highly specific antimicrobial agent in those organisms in which the interpeptide structure is essential (60) . Alternatively, in organisms in which the peptidoglycan interpeptide is dispensable, such as penicillin-resistant pneumococci, a FemABX inhibitor would certainly restore the activities of ␤-lactams. As a supporting strategy, the virulence of epidemic strains could be reduced (74) by preventing the attachment of cell wall-linked proteins via inhibition of the FemABX homologs and subsequent impairment of sorting of these virulence factors. In addition, peptidoglycan itself has been identified as a virulence factor eliciting host responses (113, 116) . In analogy to mutation of femAB (64) , it is conceivable that inhibition of FemABX factors might lead to a reduction in cell wall turnover or peptidoglycan "shedding" and thus reduce virulence. In the near future, as broad-spectrum antimicrobials become increasingly unreliable, the use of a FemABX inhibitor might be an option to be explored.
